A detailed history of Providence First Trust CO transactions in Pfizer Inc stock. As of the latest transaction made, Providence First Trust CO holds 13,837 shares of PFE stock, worth $383,284. This represents 0.17% of its overall portfolio holdings.

Number of Shares
13,837
Previous 9,938 39.23%
Holding current value
$383,284
Previous $286,000 33.92%
% of portfolio
0.17%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $100,945 - $115,917
3,899 Added 39.23%
13,837 $383,000
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $2,889 - $3,343
-80 Reduced 0.8%
9,938 $364,000
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $5,051 - $6,594
-121 Reduced 1.19%
10,018 $513,000
Q3 2022

Oct 26, 2022

SELL
$43.76 - $53.42 $100,035 - $122,118
-2,286 Reduced 18.4%
10,139 $444,000
Q1 2022

Apr 21, 2022

BUY
$45.75 - $56.69 $568,443 - $704,373
12,425 New
12,425 $643,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $155B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Providence First Trust CO Portfolio

Follow Providence First Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence First Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Providence First Trust CO with notifications on news.